BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 23283564)

  • 1. Apoptosis imaging probe predicts early chemotherapy response in preclinical models: A comparative study with 18F-FDG PET.
    Song S; Xiong C; Lu W; Ku G; Huang G; Li C
    J Nucl Med; 2013 Jan; 54(1):104-10. PubMed ID: 23283564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide-based imaging agents targeting phosphatidylserine for the detection of apoptosis.
    Xiong C; Brewer K; Song S; Zhang R; Lu W; Wen X; Li C
    J Med Chem; 2011 Mar; 54(6):1825-35. PubMed ID: 21348464
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Elvas F; Boddaert J; Vangestel C; Pak K; Gray B; Kumar-Singh S; Staelens S; Stroobants S; Wyffels L
    J Nucl Med; 2017 Apr; 58(4):665-670. PubMed ID: 27879368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.
    Takei T; Kuge Y; Zhao S; Sato M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
    J Nucl Med; 2005 May; 46(5):794-9. PubMed ID: 15872353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin.
    Elvas F; Vangestel C; Pak K; Vermeulen P; Gray B; Stroobants S; Staelens S; Wyffels L
    J Nucl Med; 2016 May; 57(5):805-11. PubMed ID: 26837335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
    Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
    J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V.
    Mochizuki T; Kuge Y; Zhao S; Tsukamoto E; Hosokawa M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
    J Nucl Med; 2003 Jan; 44(1):92-7. PubMed ID: 12515881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [
    Li Y; Liu C; Xu X; Lu X; Luo J; Gray B; Pak KY; Cheng J; Zhang Y
    Nucl Med Biol; 2018 Nov; 66():18-25. PubMed ID: 30170197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of Paclitaxel-induced apoptosis in an experimental model of virus-induced breast cancer.
    Erba PA; Manfredi C; Lazzeri E; Minichilli F; Pauwels EK; Sbrana A; Strauss HW; Mariani G
    J Nucl Med; 2010 May; 51(5):775-81. PubMed ID: 20395330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Comparison of 18F-C-SNAT to Established Radiotracer Imaging Agents for the Detection of Tumor Response to Treatment.
    Witney TH; Hoehne A; Reeves RE; Ilovich O; Namavari M; Shen B; Chin FT; Rao J; Gambhir SS
    Clin Cancer Res; 2015 Sep; 21(17):3896-905. PubMed ID: 25972517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel [
    Qiao Z; Xu J; Gonzalez R; Miao Y
    Mol Pharm; 2020 Sep; 17(9):3581-3588. PubMed ID: 32663011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time course of apoptotic tumor response after a single dose of chemotherapy: comparison with 99mTc-annexin V uptake and histologic findings in an experimental model.
    Takei T; Kuge Y; Zhao S; Sato M; Strauss HW; Blankenberg FG; Tait JF; Tamaki N
    J Nucl Med; 2004 Dec; 45(12):2083-7. PubMed ID: 15585485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-FDG and (18)F-FLT uptake early after cyclophosphamide and mTOR inhibition in an experimental lymphoma model.
    Brepoels L; Stroobants S; Verhoef G; De Groot T; Mortelmans L; De Wolf-Peeters C
    J Nucl Med; 2009 Jul; 50(7):1102-9. PubMed ID: 19525456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary study of imaging paclitaxel-induced tumor apoptosis with (99)Tc(m)-His10-Annexin V.
    Zheng YM; Wang F; Fang W; Hua ZC; Wang ZZ; Meng QL; Yan J
    Chin Med J (Engl); 2013; 126(15):2928-33. PubMed ID: 23924470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Phosphatidylserine with a
    Perreault A; Richter S; Bergman C; Wuest M; Wuest F
    Mol Pharm; 2016 Oct; 13(10):3564-3577. PubMed ID: 27608290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 99mTc- and 111In-labeled alpha-melanocyte-stimulating hormone peptides as imaging probes for primary and pulmonary metastatic melanoma detection.
    Miao Y; Benwell K; Quinn TP
    J Nucl Med; 2007 Jan; 48(1):73-80. PubMed ID: 17204701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with (99m)Tc-peptide-Z(HER2:342).
    Zhang J; Zhao X; Wang S; Wang N; Han J; Jia L; Ren X
    Nucl Med Biol; 2015 Jun; 42(6):541-6. PubMed ID: 25735223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A brief evaluation of tumor imaging in mice with 99mTc-glucarate including a comparison with 18F-FDG.
    Cheng D; Rusckowski M; Wang Y; Liu Y; Liu G; Liu X; Hnatowich D
    Curr Radiopharm; 2011 Jan; 4(1):5-9. PubMed ID: 22191610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of
    Zheng J; Miao W; Huang C; Lin H
    Ann Nucl Med; 2017 Jul; 31(6):486-494. PubMed ID: 28474165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis.
    Belhocine T; Steinmetz N; Hustinx R; Bartsch P; Jerusalem G; Seidel L; Rigo P; Green A
    Clin Cancer Res; 2002 Sep; 8(9):2766-74. PubMed ID: 12231515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.